/Johnson%20%26%20Johnson%20location%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. With a market cap of $366.4 billion, the company operates through its Innovative Medicine and MedTech segments.
The healthcare major is set to unveil its second-quarter results before the markets open on Wednesday, July 16. Ahead of the event, analysts expect JNJ to report a non-GAAP earnings of $2.65 per share, down 6% from the profit of $2.82 per share reported in the year-ago quarter. On a positive note, the company has surpassed the Street’s bottom-line projections in each of the past four quarters.